Given the high mortality associated with gastric variceal hemorrhage, ongoing investigation into pharmacologic and interventional approaches remains critical to improving patient outcomes.
Rural South Texas hospitals and physicians face mounting strain as rising uninsured rates and federal funding cuts threaten access to essential health care.
The FDA has approved Enbumyst offering a self-administered outpatient option for managing edema in patients with heart failure, liver disease, and kidney disease.